What is the approach taken if a patient is confirmed to have toxoplasmosis during pregnancy?

When a patient is confirmed to have toxoplasmosis during pregnancy, the recommended approach is to start prophylactic treatment with spiramycin. This medication has been shown to reduce the risk of vertical transmission of the parasite from the mother to the fetus. Toxoplasmosis can lead to serious complications in the developing fetus, including neurological damage and ocular diseases, so early intervention is crucial in minimizing these risks.

Spiramycin is particularly effective because it helps to keep the infection localized and reduces the maternal-fetal transmission. Early treatment can significantly improve outcomes for the baby, making this approach a standard part of managing a confirmed toxoplasmosis case during pregnancy. While close monitoring and specialty referral might be considered in complex cases, the first-line intervention for confirmed toxoplasmosis remains the initiation of prophylactic treatment.